402 related articles for article (PubMed ID: 19419344)
1. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.
Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A
Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344
[TBL] [Abstract][Full Text] [Related]
2. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy.
Sadosky A; Mardekian J; Parsons B; Hopps M; Bienen EJ; Markman J
J Diabetes Complications; 2015 Mar; 29(2):212-7. PubMed ID: 25498300
[TBL] [Abstract][Full Text] [Related]
3. Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.
Zhao Y; Ye W; Boye KS; Holcombe JH; Swindle R
Diabet Med; 2009 Jan; 26(1):61-9. PubMed ID: 19125762
[TBL] [Abstract][Full Text] [Related]
4. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
5. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.
Zhao Y; Ye W; Boye KS; Holcombe JH; Hall JA; Swindle R
J Diabetes Complications; 2010; 24(1):9-19. PubMed ID: 18930413
[TBL] [Abstract][Full Text] [Related]
7. The association of comorbidities, utilization and costs for patients identified with low back pain.
Ritzwoller DP; Crounse L; Shetterly S; Rublee D
BMC Musculoskelet Disord; 2006 Sep; 7():72. PubMed ID: 16982001
[TBL] [Abstract][Full Text] [Related]
8. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs.
Dworkin RH; Malone DC; Panarites CJ; Armstrong EP; Pham SV
J Pain; 2010 Apr; 11(4):360-8. PubMed ID: 19853529
[TBL] [Abstract][Full Text] [Related]
9. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
Margolis J; Cao Z; Fowler R; Harnett J; Sanchez RJ; Mardekian J; Silverman SL
J Med Econ; 2010; 13(4):738-47. PubMed ID: 21091395
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
[TBL] [Abstract][Full Text] [Related]
13. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
14. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
[TBL] [Abstract][Full Text] [Related]
15. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
Fillit H; Hill JW; Futterman R
Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
[TBL] [Abstract][Full Text] [Related]
16. Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus.
Rosenzweig JL; Weinger K; Poirier-Solomon L; Rushton M
Am J Manag Care; 2002 Nov; 8(11):950-8. PubMed ID: 12437310
[TBL] [Abstract][Full Text] [Related]
17. Painful diabetic peripheral neuropathy in a managed care setting: patient identification, prevalence estimates, and pharmacy utilization patterns.
Hartsfield CL; Korner EJ; Ellis JL; Raebel MA; Merenich J; Brandenburg N
Popul Health Manag; 2008 Dec; 11(6):317-28. PubMed ID: 19108647
[TBL] [Abstract][Full Text] [Related]
18. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
19. Diabetic peripheral neuropathy: resource utilization and burden of illness.
Mehra M; Merchant S; Gupta S; Potluri RC
J Med Econ; 2014 Sep; 17(9):637-45. PubMed ID: 24888404
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
